Fidelity Investments’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-440
| Closed | -$439 | – | 5764 |
|
|
2023
Q3 | $439 | Sell |
440
-91,675
| -100% | -$70.3K | ﹤0.01% | 4723 |
|
|
2023
Q2 | $45.1K | Sell |
92,115
-3,341
| -4% | -$2.73K | ﹤0.01% | 3480 |
|
|
2023
Q1 | $111K | Sell |
95,456
-4,565
| -5% | -$8.35K | ﹤0.01% | 3180 |
|
|
2022
Q4 | $268K | Buy |
100,021
+10,144
| +11% | +$26.7K | ﹤0.01% | 2918 |
|
|
2022
Q3 | $257K | Buy |
89,877
+21,341
| +31% | +$90.7K | ﹤0.01% | 2984 |
|
|
2022
Q2 | $341K | Buy |
68,536
+67,132
| +4,781% | +$352K | ﹤0.01% | 2966 |
|
|
2022
Q1 | $10K | Sell |
1,404
-1,961,794
| -100% | -$16.2M | ﹤0.01% | 4260 |
|
|
2021
Q4 | $35.7M | Sell |
1,963,198
-22,208
| -1% | -$479K | ﹤0.01% | 1567 |
|
|
2021
Q3 | $38.8M | Buy |
1,985,406
+1,307,740
| +193% | +$49.7M | ﹤0.01% | 1528 |
|
|
2021
Q2 | $30.4M | Sell |
677,666
-389,583
| -37% | -$18.1M | ﹤0.01% | 1667 |
|
|
2021
Q1 | $53.6M | Sell |
1,067,249
-282,399
| -21% | -$19.3M | ﹤0.01% | 1367 |
|
|
2020
Q4 | $121M | Buy |
1,349,648
+315,946
| +31% | +$26.6M | 0.01% | 952 |
|
|
2020
Q3 | $78.9M | Buy |
+1,033,702
| New | +$65.6M | 0.01% | 1022 |
|
Fidelity Investments's CELL Position: Q4 2023 in Review
Fidelity Investments sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 440 shares — an estimated $439 sold.
Fidelity Investments first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $121M in Q4 2020. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Fidelity Investments reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Fidelity Investments sold 440 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $439.
- Fidelity Investments first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Fidelity Investments's PhenomeX Inc. Common Stock position peaked at $121M in Q4 2020.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.